Elmind Capital, LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
EC Elmind Capital, LP | Institutional Filer | ▲ 3.94% | $352.2M | 34 |
Current Portfolio Holdings
Showing all 34 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | COGT | Cogent Biosciences, Inc. | Healthcare | 1.2M | $45.1M | 12.79% |
| 2 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 1.9M | $43.3M | 12.30% |
| 3 | CLDX | Celldex Therapeutics, Inc. | Healthcare | 865K | $27.4M | 7.79% |
| 4 | CTMX | CytomX Therapeutics, Inc. | Healthcare | 4.5M | $21.4M | 6.07% |
| 5 | KALV | KalVista Pharmaceuticals, Inc. | Healthcare | 1.0M | $20.6M | 5.84% |
| 6 | CGON | CG Oncology, Inc. Common stock | Healthcare | 292K | $19.7M | 5.61% |
| 7 | VERA | Vera Therapeutics, Inc. | Healthcare | 483K | $19.4M | 5.51% |
| 8 | PCVX | Vaxcyte, Inc. | Healthcare | 317K | $18.4M | 5.22% |
| 9 | PHVS | Pharvaris N.V. | Healthcare | 476K | $13.4M | 3.82% |
| 10 | TYRA | Tyra Biosciences, Inc. | Healthcare | 350K | $13.4M | 3.81% |
| 11 | BEAM | Beam Therapeutics Inc. | Healthcare | 476K | $11.4M | 3.22% |
| 12 | VRDN | Viridian Therapeutics, Inc. | Healthcare | 535K | $10.5M | 2.97% |
| 13 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 1.0M | $9.5M | 2.70% |
| 14 | UTHR | United Therapeutics Corporation | Healthcare | 15K | $8.9M | 2.53% |
| 15 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | 530K | $7.5M | 2.14% |
Showing 1 to 15 of 34 holdings